Comment from General Clinical Research Center

Summary: Dr. Lawrence G. Raisz, a professor and director at the University of Connecticut Center for Osteoporosis, argues in favor of maintaining the availability of estrogen-androgen combination drugs. He highlights their clinical benefits for bone density and formation in postmenopausal women who do not respond well to estrogen alone, noting that the combination pill also improves patient compliance.